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7.6; 37% female, 63% male) participated in a health examination which included a 
lipid proﬁ le. An index date was assigned for each study participant using the date of 
their exam and statin medication usage was determined through the pharmacy claims 
database for 365 days before the index date. Patients were identiﬁ ed as adherent to 
statins if their medication possession ratio (MPR) was at least 80%. RESULTS: Statin
use increased over the study period with 150 (9.3%) executives ﬁ lling at least one 
statin prescription in the 365 days prior to their exam. A total of 102 statin users
(68%) were adherent to statin medication. Among all patients who received statin 
treatment, 70% (OR  2.33, 95% CI  1.54, 3.51) achieved near optimal ( 130 mg/
dL) and 30% (OR  1.78, 95% CI  1.15, 2.76) achieved optimal ( 100 mg/dL)
LDL-C goals which are signiﬁ cantly higher than the rates among statin non-users 
(55% and 21%). Both adherent statin users and nonadherent statin users were more 
likely to achieve recommended near optimal LDL-C goals compared to executives who
were not taking statins (overall p  0.002; adherent: OR  2.75, 95%CI 1.662, 4.550; 
nonadherent: OR  1.70, 95% CI 0.884, 3.268.) CONCLUSIONS: Among executives
who participated in a periodic health examination, statin usage appears to be associ-
ated with improvements in LDL-C goal attainment. Appropriate medication usage and 
adherence to medication should be encouraged in working populations.
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EFFECT OF ACE INHIBITORS/ARBS AND STATINS ON THE INCIDENCE
OF DEMENTIA, IN PATIENTS WITH CHRONIC HEART FAILURE
Agarwal SJ, Johnson ML
University of Houston, Houston, TX, USA
OBJECTIVES: To determine the effect of ACE Inhibitors/ARBs and statins on the
incidence of dementia, in patients with Chronic Heart Failure (CHF). METHODS:
A national retrospective cohort of Veterans Affairs (VA) patients, with at least 
one outpatient claim of CHF from October 1, 1996 to September 30, 2000,
was identiﬁ ed. Drug exposure was analyzed from October 1, 1998 to September
30, 2000 and outcome of dementia (yes/no) was identiﬁ ed, based on ICD-9-CM
codes, from October 1, 2000 to September 1, 2002. Patients with non-utilization of 
VA services for two years and prevalent cases of dementia were excluded. A Cox
proportional hazards model of time to dementia diagnosis was constructed to test the
association of drug use with dementia, adjusted for socio-demographics, co-morbidi-
ties and co-medications. RESULTS: Out of 242,734 patients, 2.77% developed 
dementia during follow-up. About 75% were elderly and 79% had hypertension. 
Females, African-Americans had signiﬁ cantly higher risk of dementia than males, 
whites, respectively. Risk of dementia increased progressively with age. In adjusted 
analyses, hypertension (HR: 1.157, 95% CI: 1.078–1.240), diabetes (HR: 1.105, 95% 
CI: 1.051–1.161), and cerebrovascular disease (HR: 1.577, 95% CI: 1.489–1.671) 
signiﬁ cantly increased risk of dementia. Adjusted analyses of one-year (HR: 0.988, 
95% CI: 0.911–1.071) or two-year (HR: 0.991, 95% CI: 0.930–1.057) exposure 
to ACE Inhibitors did not signiﬁ cantly affect dementia. Adjusted analyses of one-
year exposure to ARBs (HR: 0.784, 95% CI: 0.634–0.969), statins (HR: 0.906, 
95% CI: 0.839–0.979) and two-year exposure to ARBs (HR: 0.711, 95% CI: 
0.594–0.852), statins (HR: 0.884, 95% CI: 0.829–0.943) had protective effect on
incidence of dementia. Two-year drug exposure had increased protective effect, com-
pared to one-year exposure. CONCLUSIONS: Study suggests potential beneﬁ cial 
effects, to delay onset of dementia, associated with use of ARBs and statins. Thus, 
prescribing of such agents in pharmacotherapeutic regimens of CHF patients should 
be encouraged.
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ESTIMATE THE 10-YEAR CARDIOVASCULAR RISK IN THE GENERAL
PUBLIC OF HONG KONG
Lee VWY, Law SL, Lee KK
The Chinese University of Hong Kong, Shatin, Hong Kong
OBJECTIVES: Coronary heart disease (CHD) is a major health issue in Hong Kong
and has become the second leading cause of death since the 1960s. Figures from the 
Hong Kong Department of Health Statistics have shown that in the year 2005, 
approximately 11 persons died from CHD each day. The prevalence of CHD and its
mortality in Hong Kong are approaching a level that requires focused attention.
Unfortunately, CHD could be a silent disease until the manifestations occur. Therefore, 
early detection and control of cardiovascular risk factors including cholesterol and
blood pressure is vital. In view of this point, the current project aimed to investigate 
the 10-year cardiovascular risk in the general public of Hong Kong. METHODS: A
12-month prospective public screening of lipid panels and blood pressure for the esti-
mation of 10-year cardiovascular risk was conducted in the general public of Hong 
Kong between April 2007 and April 2008. RESULTS: During this period, a total of 
2,607 patients were recruited with the mean age of 46.4/11.1 years old (51.3%
male) and 8.1% of subjects were active smokers. Among all of the subjects, the mean
total cholesterol was 5.42/1.28 mmol/L and the mean high density cholesterol was
1.59/0.75 mmol/L. The mean systolic blood pressure was 121.7/19.5 mmHg. The
assessment of the 10-year cardiovascular risk showed that 13.8% of the subjects were
moderately high to high risk patients. CONCLUSIONS: The project demonstrated
that the general public in Hong Kong had relatively high total cholesterol and normal-
high systolic blood pressure. There were almost 2 in every 10 Hong Kong citizens may
have a 10–20% or more than 20% risk to develop CHD in the next 10 years. As a 
result, good lifestyle modiﬁ cation and regular health screening are essential and 
urgently required to lower the cardiovascular risk in the general public of Hong 
Kong.
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PREVALENCE, AWARENESS, AND MANAGEMENT OF HYPERTENSION, 
DYSLIPIDEMIA, AND DIABETES AMONG UNINSURED AND INSURED 
ADULTS IN THE UNITED STATES
McDonald M1, Hertz RP1, Lustik MB2, Unger AN1
1Pﬁ zer, New York, NY, USA, 2Science Applications International Corporation, Reston, VA, USA
OBJECTIVES: National estimates of cardiovascular risk factor prevalence, awareness, 
treatment, and control among adults without health insurance are lacking. This study 
contributes to our knowledge by examining current national estimates for hyperten-
sion, dyslipidemia, and diabetes among uninsured, non-Medicaid insured, and 
Medicaid-insured adults aged 18 through 64 years. METHODS: Cross-sectional
observational study design. Analysis of adults 18 through 64 years of age surveyed in 
the National Health and Nutrition Examination Survey (NHANES) 2003–2006 (N 
8,500). RESULTS: Of an estimated 178.6 million working-age adults, 21.8% (95%
conﬁ dence interval [CI]  19.6%– 24.1%) lack health insurance. Hypertension preva-
lence is signiﬁ cantly lower in the uninsured compared with the non-Medicaid insured 
(18.9% and 21.8%, age and gender adjusted) as are rates of awareness (62.8% vs 
77.0%) and treatment (43.9% vs 65.5%). Medicaid-insured adults have a signiﬁ cantly 
higher prevalence of hypertension (29.1%) than the non-Medicaid insured. There is
no signiﬁ cant difference between the uninsured and non-Medicaid insured with respect
to adjusted prevalence of dyslipidemia (27.4% and 25.3%) or type-2 diabetes (6.4%
and 6.0%). Awareness and treatment rates for dyslipidemia are signiﬁ cantly lower in
the uninsured compared with the non-Medicaid insured (38.8% vs 64.7% for aware-
ness; 18.0% vs 41.4% for treatment). Treatment rates for diabetes are also signiﬁ -
cantly lower for the uninsured (39.9% vs 62.5%). Multivariable logistic regression
controlling for age, gender, race, education, access to care, and marital status indicate
that the uninsured are signiﬁ cantly less likely than the non-Medicaid insured to be 
aware of and treated for their dyslipidemia and less likely to be treated for their dia-
betes. CONCLUSIONS: Dyslipidemia and diabetes are less likely to be detected or 
treated among the uninsured compared with the non-Medicaid insured, calling for 
effective approaches to reduce these disparities.
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VARIATION OF SEASONAL, WEEKLY AND DAILY RHYTHM OF ACUTE
MYOCARDIAL INFARCTION IN DIABETIC PATIENTS
Gabara K1, Boncz I1, Csoboth I1, Szovak E1, Varga A1, De Blasio A1, Bódi J1, Kriszbacher I2
1University of Pécs, Pécs, Hungary, 2University of Pécs, Pecs, Hungary
OBJECTIVES: The purpose of this study was to examine whether there is a difference 
in the seasonal, weekly and daily variation of acute myocardial infarction in patients
who were diabetic and who were not, and to get information about the mechanism 
of the background of the rhythm variation and about the triggering effects. METHODS:
Retrospective analysis was made with acute myocardial infarction patients received in
almost all hospitals in Hungary between 2005 and 2007 (n  41.510, 23.993 male, 
17.517 female). Data were collected from the database of the National Health Insur-
ance Fund Administration based on ICD codes: I21, I22, E1000–1490. RESULTS:
With regard to seasonal variation, the peek period of acute myocardial infarction was
found during the months of spring, the lowest number of events is during the summer.
There was a signiﬁ cant difference between the number of events for each season (p 
0.003). The weekly peek period of acute myocardial infarction was found on the ﬁ rst
day of the week, on Monday, with a gradually decreasing tendency towards the end 
of the week, until Sunday. The decrease is much higher in the weekend. Regarding the 
daily rhythm, the results were signiﬁ cant. The peek period was found in the morning
hours of the day, and the lowest number of acute myocardial infarction was in the 
evening hours (p  0,001). In case of patients with diabetes (5.739 male, 5.376 female) 
the results were similar, the seasonal variation in the occurrence of acute myocardial 
infarction is also signiﬁ cant, such as the results of the weekly and daily rhythm (p 
0.025, p  0.000). CONCLUSIONS: In summary, it can be said that the results of our 
study show that the incidence of an acute myocardial infarction shows characteristic 
variation with regard to seasons and the days of the week, but there are no differences 
between diabetic and non-diabetic patients.
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SEASONAL, WEEKLY AND DAILY VARIATION OF ACUTE MYOCARDIAL
INFARCTION AND TRANSIENT ISCHEMIC ATTACK IN HUNGARY
Kriszbacher I1, Boncz I2, Gazdag L2, Mátyus A2, Vránics I2, Csoboth I2, De Blasio A2, 
Zsigmond E2, Betlehem J1, Oláh A1, Bódis J1
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OBJECTIVES: The purpose of our study was to observe whether a seasonal change
or weekly variation can be shown in the incidence of an acute myocardial infarction 
(AMI) and a transient ischemic attack (TIA) during a three-year study period in 
Hungary. We also examined whether the occurrence of an AMI or a TIA is inﬂ uenced
by age and sex. METHODS: We have analyzed AMI (N  51,802) and TIA (N 
12,592) patients received at clinics and hospitals in Hungary between 2005 and 2007.
Data were collected from the database of the National Social Security Fund (OEP) 
based on the International Classiﬁ cation of Diseases (ICD codes). RESULTS: Based 
on our results, a weekly and a seasonal variation can be seen in the onset of a transient 
ischemic attack and an acute myocardial infarction. With regard to seasonal variation, 
there was a signiﬁ cant difference between the number of events for each season (p 
0.01), and the peek period of AMI and TIA was found during the months of spring, 
the lowest number of events of AMI is during the summer and in the case of TIA is 
in autumn. In case of sexes, difference was only found in the seasonal variation of 
number of events of AMI (p  0.01). The weekly peek period of infarction and cerebral 
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circulatory disturbance was found on the ﬁ rst day of the week, on Monday, with a 
gradually decreasing tendency towards the end of the week. Examination of variation 
according to age groups showed a signiﬁ cant difference only in case of TIA with con-
sideration to daily variation. CONCLUSIONS: The decrease is higher from Friday to
Sunday. In summary, the results of our study show that the incidence of an acute
myocardial infarction and a transient ischemic attack shows characteristic variation
with regard to seasons and the days of the week.
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DAILY ALCOHOL CONSUMPTION AND RACE/ETHNICITY: THEIR
RELATIONSHIP TO STROKE OR CORONARY ARTERY DISEASE IN THE
US ADULT POPULATION
Becker TL, Campbell HM
Department of Veterans Affairs Cooperative Studies Program, Albuquerque, NM, USA
OBJECTIVES: Atherosclerotic disease is the leading cause of mortality in the US.
Modiﬁ able and non-modiﬁ able risk factors need to be studied simultaneously for
stroke and coronary artery disease (CAD). We examined the association between daily 
alcohol consumption, race/ethnicity, stroke and CAD. METHODS: We used the 2005 
Behavioral Risk Factor Surveillance System (BRFSS), a nationally representative cross-
sectional survey. We performed Chi-square tests to determine associations between 
daily alcohol consumption (1, 1–2, and 2 drinks) and race/ethnicity (Black, Asian,
Native Hawaiian/Paciﬁ c Islander, American Indian/Alaskan Native, White, Hispanic, 
Multiracial, and Other) with stroke and CAD. Identifying daily alcohol consumption
and race/ethnicity as independent variables and stroke or CAD as dependent variables, 
we assessed the relationships in multivariate logistic regression after controlling for
modiﬁ able and non-modiﬁ able risk factors. Modiﬁ able risk factors included hyperten-
sion, hyperlipidemia, diabetes, body mass index, exercise, daily fruit/vegetable con-
sumption, smoking status, education, and income. Non-modiﬁ able risk factors 
included gender and age. RESULTS: We analyzed 269,554 cases. Compared to those
having 2 drinks/day, individuals who reported 1 drink/day were found to have 1.36 
[95%CI  1.14–1.63] greater odds of stroke [p  0.001] and 1.33 [95%CI  1.17–
1.51] greater odds of CAD [p  0.0001]. For stroke and CAD, American Indians/
Alaskan Natives had 1.65 [95%CIs  1.41–1.94] and 1.41 [95%CI  1.24–1.62] 
greater odds, respectively, than Whites [p  0.0001 each]. Hispanics had 0.70 [95%CI
 0.62–0.79] lower odds of stroke [p  0.0001] while Blacks had 1.18 [95%CI 
1.08–1.28] greater odds [p  0.0001] than Whites. Blacks had 0.76 [95%CI  0.70–
0.82] and Asians had 0.74 [95%CI  0.61–0.90] lower odds of CAD than Whites [p 
 0.0001 each]. CONCLUSIONS: Although there are similar ﬁ ndings between those
having 1–2 and 2 drinks/day, we do not advise drinking above the dietary guidelines; 
other information does not support this action. We note existing literature supports
a beneﬁ cial effect of having 1–2 drinks/day compared to 1 on stroke and CAD.
Race/ethnicity is strongly associated with stroke and CAD.
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SMOKING AND STROKE IN THE CHINESE SMOKING POPULATION
Wang L1, Li Y2
1Sichuan University, Chengdu, Sichuan, China, 2West China Hospital, Sichuan University, 
Chengdu, China
OBJECTIVES: Worldwide, the association of passive smoking with development of 
stroke has been ascertained. However, it remains unknown of the magnitude of the 
association in the Chinese population. We thus systematically reviewed the published 
studies worldwide. METHODS: We searched Medline, EMBASE, and three other 
Chinese databases from their inception to June, 2008. We included case-control and
cohort studies that investigated the association of smoking with stroke, and that pro-
vided data on the magnitude of the association. Two reviewers screened the eligibility,
assessed the extent of the bias, and extracted data independently. We obtained the 
unadjusted and adjusted estimates of studies. We pooled the trial data using the
random-effect model and explored the heterogeneity by the pre-speciﬁ ed variables. 
RESULTS: We included 49 studies (n  58,872), 8 of which were cohort studies (n 
42,755) and 41 case-control studies (cumulative cases 7 883, controls 9 590). Smoking 
increased the risk of stroke by 75% (OR 1.75, 95%CI 1.51 to 2.03). Pooling of 
adjusted estimates of 31 studies (n  26,028) showed the risk of stroke was increased
by 81% in smokers (1.81, 1.57 to 2.08). The magnitude of the association was not
statistically different in different type of strokes: hemorrhagic stroke 1.65 (1.29 to 
2.11) and ischemic stroke 1.79 (1.20 to 2.68). No dose-response relationship was
found between amount of smoking and the risk of stroke. CONCLUSIONS: The 
increased risk of stroke associated with smoking in the Chinese population has been 
ascertained.
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HEALTH CARE UTILIZATION AND RISK OF CARDIOVASCULAR
DISEASE ASSOCIATED WITH METABOLIC SYNDROME
Zang W1, Liu G2, Luo N3
1Southwestern University of Finance and Economics, Chengdu, Sichuan, China, 2Peking
University, Beijing, Beijing, China, 3National University of Singapore, Singapore, Singapore
OBJECTIVES: To analyze the health care utilization and risk proﬁ les of patients 
with metabolic syndrome (MS) based on subgroups identiﬁ ed by a latent class 
analysis. METHODS: Utilizing the medical record database from GE Healthcare, we
estimate a set of regressions to take a closer look at the effect of metabolic syndrome 
(MS) on patients’ hospital admission, ofﬁ ce visit, and the risk of developing one par-
ticular type of cardiovascular disease, coronary heart disease (CHD). Patients are 
identiﬁ ed as having MS by using the guidelines proposed by the National Cholesterol 
Education Program Adult Treatment Panel III. We conduct the analysis in this study 
in the following steps; ﬁ rst, we adopt negative binominal regression models to estimate
the effect of MS on hospital admission and ofﬁ ce visit; second, Probit models are 
applied to examine the relationship between MS and CHD; and third, the results from 
the Latent Class Analysis, which identiﬁ es ﬁ ve subgroups of MS patients by risk 
factors, are integrated into the regression estimations. RESULTS: We ﬁ nd 1) that
patients with MS have higher number of hospital admissions and ofﬁ ce visits, and
are more likely to develop CHD than those without MS, and 2) that MS patients 
with abnormal blood pressure are more likely to be hospitalized than MS patients
with normal blood pressure. Strikingly, we ﬁ nd, by integrating the results from a 
latent class analysis, that MS patients with the simultaneous presence of three risk
factors, abnormal HDL, waist circumference, and blood pressure, are more likely to 
develop CHD than other types of MS patients. CONCLUSIONS: LCA offers a useful
method to help better classify MS patients into sub groups by shared group-speciﬁ c 
characteristics that would be hard to measure otherwise. Based on the LCA study, we 
conﬁ rm that MS patients with multiple risk factors are more likely to develop CHD 
conditions.
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THE PREDICTION OF STROKE AND MORTALITY OUTCOMES IN
PATIENTS WITH ATRIAL FIBRILLATION MAINTAINING SINUS RHYTHM
WITH AND WITHOUT ANTIARRHYTHMIC DRUGS
Xenakis JG1, Quon P2, Getsios D3, White SA4, Khaykin Y5
1United BioSource Corporation, Lexington, MA, USA, 2United BioSource Corporation, 
Bethesda, MD, USA, 3United BioSource Corporation, Concord, MA, USA, 4Biosense Webster, 
Inc, Diamond Bar, CA, USA, 5Southlake Regional Health Centre, Newmarket, ON, Canada
Atrial ﬁ brillation (AF) poses a substantial health burden. While analyses of the 
AFFIRM study showed that maintenance of sinus rhythm (SR) reduced the risk of 
stroke and death, due to their toxicity, antiarrhythmic drug (AAD) use was found to
be independently associated with increased mortality. OBJECTIVES: To estimate the 
beneﬁ ts of SR maintenance, in order to understand the potential improvements of 
maintaining SR with alternatives to AADs, such as ablation. METHODS: A discrete 
event simulation (DES) was developed predicting stroke and death in a population
with AF using equations from AFFIRM. Individual patients were created and assigned 
unique attributes. Analyses were run over a ten year time horizon, wherein the AF
burden (the time spent out of SR) was allowed to vary from 0 to 50%. Scenarios were
evaluated wherein SR was attained with and without use of AADs. RESULTS: Under 
the assumption of perfect rhythm control, 17.1% of patients controlled with AADs
were predicted to die, compared to only 12.8% of those controlled without AADs;
5.9% and 6.2% of these populations were predicted to have strokes, respectively. 
Strokes were higher in latter cohort because of improved survival. When the AF 
burden was increased to 25%, 19.5% and 14.6% were predicted to die, while 6.6% 
and 6.8% were predicted to have a stroke, respectively. A further increase of the AF
burden to 50% resulted in predicted mortality of 22.1% and 16.7%, and stroke rates
of 7.2% and 7.6%, respectively. CONCLUSIONS: Maintenance of SR improves sur-
vival in patients with AF, and without the use of AAD was predicted to yield a sub-
stantial incremental survival beneﬁ t. These results indicate that techniques like
ablation, which have been shown to be more effective than AAD for converting and
maintaining SR would have important beneﬁ ts in an AF population.
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THE CLINICAL IMPACT OF DIFFERENCES BETWEEN TWO MEASURES
OF THE INTERNATIONAL NORMALIZED RATIO (INR)
Shermock KM1, Pinto BL2, Streiff M2
1The Johns Hopkins Hospital, Baltimore, MD, USA, 2The Johns Hopkins Medical Institutions, 
Baltimore, MD, USA
OBJECTIVES: To assess the clinical impact of disagreement between two methods of 
measuring INR in our anticoagulation clinics. METHODS: We assessed paired INR 
samples collected from the same patient at the same visit from 4 anticoagulation clinics 
associated with the Johns Hopkins Medical Institutions. One venous sample was 
analyzed in the Johns Hopkins Coagulation Laboratory and one ﬁ ngerstick sample
was analyzed by the Hemochron Signature Plus POC device (International Techni-
dyne Corporation, Edison, NJ, USA). A newly-developed analytic technique was
applied that reports results in explicitly clinical terms. RESULTS: Samples were col-
lected from 1666 patients from January, 2006 through June, 2008. The lab was nearly
twice as likely to report a value below the target INR range of 2–3 compared with 
the POC (36% vs. 19%). Furthermore, the lab was almost four times more likely to 
report that the INR was 1.0–1.49 – a range associated with a 13.5-fold increased risk 
of a thromboembolic event (18% vs. 5%). Overall, 29% of clinical decisions were 
projected to differ, depending on which measure was used. A majority (53%) of the
predicted clinical differences occurred when the POC device reported a value within 
the target INR range. Based on epidemiologic evidence of risk as a function of the
INR, we estimate that 67 thromboembolic events occurred over the 2.5 year period 
because of the discrepancy between the measures. CONCLUSIONS: There are clini-
cally relevant differences between INR values reported by the Hemochron POC device
and our clinical lab that were not detected by conventional methods. The Hemochron
device biases INR measures towrd the target range throughout the INR scale. This 
bias prevents many necessary warfarin dosing changes because the clinician does not 
understand the patient’s true risk level. Therefore, patients spend more time at INR 
levels strongly associated with an increased risk of a negative outcome.
